Piper Sandler Maintains Overweight on I-MAB, Lowers Price Target to $10
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Joseph Catanzaro has maintained an Overweight rating on I-MAB (NASDAQ:IMAB) but has lowered the price target from $15 to $10.
March 18, 2024 | 11:16 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Piper Sandler maintains an Overweight rating on I-MAB but lowers the price target from $15 to $10.
The reduction in price target by Piper Sandler, despite maintaining an Overweight rating, could lead to short-term negative sentiment among investors, potentially impacting the stock price negatively.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100